These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24147046)

  • 1. Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistance.
    Zheng DP; Rodrigues M; Bile E; Nguyen DB; Diallo K; DeVos JR; Nkengasong JN; Yang C
    PLoS One; 2013; 8(10):e77649. PubMed ID: 24147046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey.
    Bussmann H; de la Hoz Gomez F; Roels TH; Wester CW; Bodika SM; Moyo S; Taffa N; Anderson MG; Mine M; Bile EC; Yang C; Mphoyakgosi K; Lehotzky EA; Mlotshwa B; Mmelesi M; Seipone K; Makhema MJ; Marlink RG; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2011 Apr; 27(4):365-72. PubMed ID: 21034246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa.
    Parboosing R; Naidoo A; Gordon M; Taylor M; Vella V
    J Med Virol; 2011 Sep; 83(9):1508-13. PubMed ID: 21739439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.
    Nguyen HT; Duc NB; Shrivastava R; Tran TH; Nguyen TA; Thang PH; McNicholl JM; Leelawiwat W; Chonwattana W; Sidibe K; Fujita M; Luu CM; Kakkar R; Bennett DE; Kaplan J; Cosimi L; Wolfe MI
    Antivir Ther; 2008; 13 Suppl 2():115-21. PubMed ID: 18575200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT).
    DeVos J; McCarthy K; Sewe V; Akinyi G; Junghae M; Opollo V; Nouhin J; Shafer R; Zeh C; Ramos A; Alexander H; Chang J
    Microbiol Spectr; 2022 Jun; 10(3):e0177621. PubMed ID: 35510849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
    Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE
    PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in Ndola, Zambia.
    Miti S; Handema R; Mulenga L; Mwansa JK; Abrams E; Frimpong C; Burke VM; Zulu M; Siwingwa M; Mwakazanga D; Kalibala S; Denison JA
    PLoS One; 2020; 15(8):e0236156. PubMed ID: 32804970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.
    Zhou Z; Wagar N; DeVos JR; Rottinghaus E; Diallo K; Nguyen DB; Bassey O; Ugbena R; Wadonda-Kabondo N; McConnell MS; Zulu I; Chilima B; Nkengasong J; Yang C
    PLoS One; 2011; 6(11):e28184. PubMed ID: 22132237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients.
    Nanfack AJ; Redd AD; Bimela JS; Ncham G; Achem E; Banin AN; Kirkpatrick AR; Porcella SF; Agyingi LA; Meli J; Colizzi V; Nádas A; Gorny MK; Nyambi PN; Quinn TC; Duerr R
    J Clin Microbiol; 2017 Sep; 55(9):2785-2800. PubMed ID: 28659324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients.
    Kiertiburanakul S; Chaiwarith R; Sirivichayakul S; Ditangco R; Jiamsakul A; Li PC; Kantipong P; Lee C; Ratanasuwan W; Kamarulzaman A; Sohn AH; Sungkanuparph S;
    PLoS One; 2013; 8(6):e62057. PubMed ID: 23826076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low level of transmitted HIV Drug resistance at two HIV care centres in Ghana: a threshold survey.
    Bonney EY; Addo NA; Ntim NA; Addo-Yobo F; Bondzie P; Aryee KE; Barnor J; Brandful J; Bekoe V; Ohene SA; Ampofo W
    Ghana Med J; 2013 Jun; 47(2):82-6. PubMed ID: 23966745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of primary resistance in HIV-1-infected treatment-naive individuals from Western India.
    Lall M; Gupta RM; Sen S; Kapila K; Tripathy SP; Paranjape RS
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):987-90. PubMed ID: 18593351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low primary and secondary HIV drug-resistance after 12 months of antiretroviral therapy in human immune-deficiency virus type 1 (HIV-1)-infected individuals from Kigali, Rwanda.
    Rusine J; Asiimwe-Kateera B; van de Wijgert J; Boer KR; Mukantwali E; Karita E; Gasengayire A; Jurriaans S; de Jong M; Ondoa P
    PLoS One; 2013; 8(8):e64345. PubMed ID: 23950859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high.
    Kasang C; Kalluvya S; Majinge C; Stich A; Bodem J; Kongola G; Jacobs GB; Mlewa M; Mildner M; Hensel I; Horn A; Preiser W; van Zyl G; Klinker H; Koutsilieri E; Rethwilm A; Scheller C; Weissbrich B
    PLoS One; 2011; 6(8):e23091. PubMed ID: 21886779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon.
    Mokhbat JM; Melhem NM; El-Khatib Z; Zalloua P
    J Infect Dev Ctries; 2014 Mar; 8(3):339-48. PubMed ID: 24619266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania.
    Somi GR; Kibuka T; Diallo K; Tuhuma T; Bennett DE; Yang C; Kagoma C; Lyamuya EF; Swai RO; Kassim S
    Antivir Ther; 2008; 13 Suppl 2():77-82. PubMed ID: 18575194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.
    Jahanbakhsh F; Hattori J; Matsuda M; Ibe S; Monavari SH; Memarnejadian A; Aghasadeghi MR; Mostafavi E; Mohraz M; Jabbari H; Kamali K; Keyvani H; Azadmanesh K; Sugiura W
    PLoS One; 2013; 8(4):e61864. PubMed ID: 23626742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys.
    Andersson E; Shao W; Bontell I; Cham F; Cuong do D; Wondwossen A; Morris L; Hunt G; Sönnerborg A; Bertagnolio S; Maldarelli F; Jordan MR
    Infect Genet Evol; 2013 Aug; 18():125-31. PubMed ID: 23583545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Sequence Data to Patient Result: A Solution for HIV Drug Resistance Genotyping With Exatype, End to End Software for Pol-HIV-1 Sanger Based Sequence Analysis and Patient HIV Drug Resistance Result Generation.
    Kingwara L; Karanja M; Ngugi C; Kangogo G; Bera K; Kimani M; Bowen N; Abuya D; Oramisi V; Mukui I
    J Int Assoc Provid AIDS Care; 2020; 19():2325958220962687. PubMed ID: 32990139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.